Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.81
HKD
|
0.00%
|
|
+1.25%
|
-20.59%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,086
|
1,698
|
1,243
|
1,065
|
1,149
|
924
|
Enterprise Value (EV)
1 |
5,613
|
1,915
|
1,494
|
1,173
|
1,256
|
941.6
|
P/E ratio
|
22.9
x
|
3.28
x
|
8.6
x
|
4.74
x
|
4.8
x
|
32.2
x
|
Yield
|
1.31%
|
5.63%
|
3.99%
|
10.3%
|
8.34%
|
7.23%
|
Capitalization / Revenue
|
3.36
x
|
0.93
x
|
0.98
x
|
0.6
x
|
0.54
x
|
0.45
x
|
EV / Revenue
|
3.7
x
|
1.05
x
|
1.17
x
|
0.66
x
|
0.59
x
|
0.46
x
|
EV / EBITDA
|
13.7
x
|
2.19
x
|
4.7
x
|
2.68
x
|
2.59
x
|
3.76
x
|
EV / FCF
|
-17.2
x
|
5.63
x
|
6.3
x
|
9.15
x
|
6.06
x
|
41.3
x
|
FCF Yield
|
-5.82%
|
17.8%
|
15.9%
|
10.9%
|
16.5%
|
2.42%
|
Price to Book
|
3.86
x
|
0.96
x
|
0.74
x
|
0.56
x
|
0.57
x
|
0.49
x
|
Nbr of stocks (in thousands)
|
1,041,846
|
1,038,396
|
1,033,104
|
1,021,228
|
1,008,413
|
996,712
|
Reference price
2 |
4.882
|
1.635
|
1.204
|
1.043
|
1.139
|
0.9271
|
Announcement Date
|
4/23/19
|
4/20/20
|
4/9/21
|
4/14/22
|
4/17/23
|
4/9/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,516
|
1,818
|
1,275
|
1,781
|
2,122
|
2,065
|
EBITDA
1 |
409.2
|
876.1
|
318.2
|
438.1
|
485.7
|
250.4
|
EBIT
1 |
343.3
|
807.7
|
225.6
|
338.2
|
384
|
96.12
|
Operating Margin
|
22.65%
|
44.42%
|
17.69%
|
18.99%
|
18.09%
|
4.65%
|
Earnings before Tax (EBT)
1 |
308.9
|
709.6
|
177.3
|
307.6
|
334.7
|
59.6
|
Net income
1 |
222.9
|
517.9
|
144.9
|
226.2
|
242
|
29.06
|
Net margin
|
14.7%
|
28.48%
|
11.36%
|
12.7%
|
11.4%
|
1.41%
|
EPS
2 |
0.2135
|
0.4984
|
0.1399
|
0.2201
|
0.2375
|
0.0288
|
Free Cash Flow
1 |
-326.6
|
340.5
|
237.3
|
128.2
|
207.2
|
22.77
|
FCF margin
|
-21.54%
|
18.72%
|
18.61%
|
7.2%
|
9.76%
|
1.1%
|
FCF Conversion (EBITDA)
|
-
|
38.86%
|
74.57%
|
29.25%
|
42.66%
|
9.1%
|
FCF Conversion (Net income)
|
-
|
65.74%
|
163.8%
|
56.64%
|
85.6%
|
78.36%
|
Dividend per Share
2 |
0.0640
|
0.0920
|
0.0480
|
0.1070
|
0.0950
|
0.0670
|
Announcement Date
|
4/23/19
|
4/20/20
|
4/9/21
|
4/14/22
|
4/17/23
|
4/9/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
527
|
217
|
251
|
108
|
107
|
17.5
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.288
x
|
0.2477
x
|
0.7885
x
|
0.2457
x
|
0.2205
x
|
0.07
x
|
Free Cash Flow
1 |
-327
|
340
|
237
|
128
|
207
|
22.8
|
ROE (net income / shareholders' equity)
|
18.1%
|
33.6%
|
8.39%
|
12.7%
|
12.7%
|
2.18%
|
ROA (Net income/ Total Assets)
|
9%
|
19.8%
|
5.73%
|
8.61%
|
8.33%
|
1.81%
|
Assets
1 |
2,475
|
2,611
|
2,530
|
2,628
|
2,907
|
1,608
|
Book Value Per Share
2 |
1.260
|
1.700
|
1.630
|
1.850
|
2.000
|
1.890
|
Cash Flow per Share
2 |
0.1200
|
0.1000
|
0.1000
|
0.1800
|
0.1900
|
0.2900
|
Capex
1 |
464
|
153
|
20.8
|
64.1
|
279
|
72.4
|
Capex / Sales
|
30.64%
|
8.44%
|
1.63%
|
3.6%
|
13.16%
|
3.51%
|
Announcement Date
|
4/23/19
|
4/20/20
|
4/9/21
|
4/14/22
|
4/17/23
|
4/9/24
|
|
1st Jan change
|
Capi.
|
---|
| -20.59% | 103M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|